We first examined the changes in the expression of THTR-1 and THTR-2 in the prefrontal cortex (PFC) and hippocampus (HIP) tissues of AD patients and (5XFAD) mouse model of AD. This evidence concerns the gene SLC19A2 and Alzheimer disease.